Dermapharm Holding SE (DMP) — Net Asset Quality Index
Dermapharm Holding SE (DMP) has a Net Asset Quality Index of 31.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €2.20 Billion minus total liabilities of €1.50 Billion yields net assets of €701.83 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check DMP asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Dermapharm Holding SE Net Asset Quality Index Over Time (2013–2025)
This chart shows how Dermapharm Holding SE's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the index stands at 31.8%, representing net assets of €701.83 Million against total assets of €2.20 Billion EUR. See working capital position of Dermapharm Holding SE to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Dermapharm Holding SE (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for Dermapharm Holding SE from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Dermapharm Holding SE (DMP) total market value.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 31.8% | €701.83 Million | €2.20 Billion | €1.50 Billion | ▲ +2.6 pp |
| 2024 | 29.2% | €608.29 Million | €2.08 Billion | €1.47 Billion | ▲ +4.0 pp |
| 2023 | 25.2% | €545.05 Million | €2.16 Billion | €1.62 Billion | ▼ -12.5 pp |
| 2022 | 37.7% | €532.49 Million | €1.41 Billion | €880.34 Million | ▲ +2.2 pp |
| 2021 | 35.5% | €499.83 Million | €1.41 Billion | €907.13 Million | ▲ +9.0 pp |
| 2020 | 26.5% | €324.58 Million | €1.22 Billion | €899.81 Million | ▼ -0.7 pp |
| 2019 | 27.2% | €284.49 Million | €1.04 Billion | €760.38 Million | ▼ -9.1 pp |
| 2018 | 36.3% | €256.08 Million | €704.58 Million | €448.50 Million | ▲ +18.6 pp |
| 2017 | 17.7% | €73.69 Million | €415.30 Million | €341.62 Million | ▼ -1.8 pp |
| 2016 | 19.5% | €60.81 Million | €311.70 Million | €250.89 Million | ▲ +4.5 pp |
| 2015 | 15.0% | €44.44 Million | €296.67 Million | €252.22 Million | ▲ +4.7 pp |
| 2014 | 10.3% | €34.01 Million | €330.60 Million | €296.59 Million | ▼ -1.5 pp |
| 2013 | 11.8% | €41.36 Million | €349.98 Million | €308.62 Million | — |